These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9224290)

  • 1. Immunity and immune privilege elicited by cultured retinal pigment epithelial cell transplants.
    Grisanti S; Ishioka M; Kosiewicz M; Jiang LQ
    Invest Ophthalmol Vis Sci; 1997 Jul; 38(8):1619-26. PubMed ID: 9224290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subretinal space and vitreous cavity as immunologically privileged sites for retinal allografts.
    Jiang LQ; Jorquera M; Streilein JW
    Invest Ophthalmol Vis Sci; 1993 Nov; 34(12):3347-54. PubMed ID: 8225870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that retinal pigment epithelium functions as an immune-privileged tissue.
    Wenkel H; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3467-73. PubMed ID: 11006240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic consequences of intraocular implantation of retinal pigment epithelial allografts.
    Jiang LQ; Jorquera M; Streilein JW
    Exp Eye Res; 1994 Jun; 58(6):719-28. PubMed ID: 7925711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic privilege evoked by histoincompatible intracameral retinal transplants.
    Jiang LQ; Streilein JW
    Reg Immunol; 1990-1991; 3(3):121-30. PubMed ID: 2098067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cyclosporine on anterior chamber-associated immune deviation with retinal transplantation.
    Ishioka M; Okamoto S; Streilein JW; Jiang LQ
    Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):2152-60. PubMed ID: 9331279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombospondin plays a vital role in the immune privilege of the eye.
    Zamiri P; Masli S; Kitaichi N; Taylor AW; Streilein JW
    Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):908-19. PubMed ID: 15728547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of immune deviation elicited by antigens injected into the subretinal space.
    Wenkel H; Streilein JW
    Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1823-34. PubMed ID: 9727405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune privilege is extended, then withdrawn, from allogeneic tumor cell grafts placed in the subretinal space.
    Wenkel H; Chen PW; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3202-8. PubMed ID: 10586943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unconventional rejection of neural retinal allografts implanted into the immunologically privileged site of the eye.
    Jiang LQ; Jorquera M; Streilein JW; Ishioka M
    Transplantation; 1995 Apr; 59(8):1201-7. PubMed ID: 7732567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and antigenicity of allogeneic amniotic epithelial transplants grafted to the cornea, conjunctiva, and anterior chamber.
    Wang M; Yoshida A; Kawashima H; Ishizaki M; Takahashi H; Hori J
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1522-32. PubMed ID: 16565388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovalbumin serves as a neo-transplantation antigen in retinal pigment epithelial cells.
    Wajchman JR; Zimring JC; Lake JP; Wen J; Kapp JA
    Mol Vis; 2007 Oct; 13():1902-11. PubMed ID: 17960129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplantation of retinal pigment epithelial cells and immune response in the subretinal space.
    Zhang X; Bok D
    Invest Ophthalmol Vis Sci; 1998 May; 39(6):1021-7. PubMed ID: 9579482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of anterior chamber-associated immune deviation by corneal allografts placed in the anterior chamber.
    Yamada J; Streilein JW
    Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2833-43. PubMed ID: 9418737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACAID induced by allogeneic corneal tissue promotes subsequent survival of orthotopic corneal grafts.
    Sonoda A; Sonoda Y; Muramatu R; Streilein JW; Usui M
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):790-8. PubMed ID: 10711695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of microglia as passenger leukocytes to the fate of intraocular neuronal retinal grafts.
    Ma N; Streilein JW
    Invest Ophthalmol Vis Sci; 1998 Nov; 39(12):2384-93. PubMed ID: 9804147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunity and immune privilege elicited by autoantigens expressed on syngeneic neonatal neural retina grafts.
    Jiang LQ; Streilein JW
    Curr Eye Res; 1992 Jul; 11(7):697-709. PubMed ID: 1521470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of superparamagnetic microbeads in tracking subretinal injections.
    Wen J; McKenna KC; Barron BC; Langston HP; Kapp JA
    Mol Vis; 2005 Apr; 11():256-62. PubMed ID: 15851980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired cell-mediated immunity in mice bearing healthy orthotopic corneal allografts.
    Sonoda Y; Streilein JW
    J Immunol; 1993 Mar; 150(5):1727-34. PubMed ID: 8436812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of anterior chamber-associated immune deviation with lymphoreticular allogeneic cells.
    Okamoto S; Hara Y; Streilein JW
    Transplantation; 1995 Feb; 59(3):377-81. PubMed ID: 7871568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.